Lobbying activity

Who's lobbying Congress, for whom, and on what — from federal Lobbying Disclosure Act filings. Covers both chambers, synced daily. 1,778 filings

Top spenders & firms Spend by issue

KOUNTOUPES DENHAM CARR & REID, LLC for AMERICAN KRATOM ASSOCIATION

1st Quarter (Jan 1 - Mar 31) 2026 · Virginia · House · Senate · $50,000.00 income

Consumer Issues/Safety/Products, Health Issues, Pharmacy

B HALL STRATEGIES, LLC for TIBER CREEK HEALTH STRATEGIES, INC. ON BEHALF OF AMGEN, INC.

1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · Senate · $50,000.00 income

B HALL STRATEGIES, LLC for TIBER CREEK HEALTH STRATEGIES, INC. ON BEHALF OF NOVARTIS

1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · Senate · $30,000.00 income

B HALL STRATEGIES, LLC for TIBER CREEK HEALTH STRATEGIES, INC. ON BEHALF OF GENENTECH, INC.

1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · Senate · $30,000.00 income

B HALL STRATEGIES, LLC for TIBER CREEK HEALTH STRATEGIES, INC. ON BEHALF OF ELI LILLY AND COMPANY

1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · Senate · $30,000.00 income

B HALL STRATEGIES, LLC for TIBER CREEK GROUP ON BEHALF OF PHLOW CORPORATION

1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · Senate · $30,000.00 income

B HALL STRATEGIES, LLC for TIBER CREEK GROUP ON BEHALF OF ORGANON, LLC

1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · Senate · $30,000.00 income

B HALL STRATEGIES, LLC for TIBER CREEK GROUP ON BEHALF OF MERCK & CO., INC.

1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · $30,000.00 income

B HALL STRATEGIES, LLC for TIBER CREEK GROUP ON BEHALF OF TAKEDA PHARMACEUTICALS AMERICA, INC.

1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · Senate · $30,000.00 income

B HALL STRATEGIES, LLC for TIBER CREEK GROUP ON BEHALF OF GILEAD SCIENCES, INC.

1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · Senate · $30,000.00 income

B HALL STRATEGIES, LLC for TIBER CREEK GROUP ON BEHALF OF DAIICHI SANKYO, INC.

1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · Senate · $30,000.00 income

B HALL STRATEGIES, LLC for TIBER CREEK GROUP ON BEHALF OF BEONE MEDICINES USA, INC.

1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · Senate · $30,000.00 income

B HALL STRATEGIES, LLC for TIBER CREEK GROUP ON BEHALF OF ASTELLAS PHARMA US, INC.

1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · $30,000.00 income

B HALL STRATEGIES, LLC for TIBER CREEK HEALTH STRATEGIES, INC. ON BEHALF OF PHRMA

1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · Senate · $50,000.00 income

340B HEALTH for 340B HEALTH

1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate

PITTMAN LAW GROUP for TRULIEVE

2nd Quarter (Apr 1 - June 30) 2026 · Florida

Health Issues, Pharmacy

HACKENSACK MERIDIAN HEALTH for HACKENSACK MERIDIAN HEALTH

1st Quarter (Jan 1 - Mar 31) 2026 · New Jersey · House · Senate

Budget/Appropriations, Science/Technology, Health Issues, Education

AEGIS LLC for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA

1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate · $60,000.00 income

Pharmacy, Health Issues

AEGIS LLC for TRIS PHARMA, INC.

1st Quarter (Jan 1 - Mar 31) 2026 · New Jersey · House · Senate · $50,000.00 income

STUMPTOWN STRATEGIES for PRIME THERAPEUTICS

1st Quarter (Jan 1 - Mar 31) 2026 · Minnesota · House · Senate · $20,000.00 income

Health Issues, Pharmacy

PANNONE LOPES DEVEREAUX & O'GARA LLC for AMGEN

1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · $9,000.00 income

E3 STRATEGIC CONSULTING GROUP for PHARMACEUTICAL INDUSTRY LABOR MANAGEMENT ASSOCIATION

1st Quarter (Jan 1 - Mar 31) 2026 · Virginia · House · $60,000.00 income

CHAMBER HILL STRATEGIES for OS THERAPIES

1st Quarter (Jan 1 - Mar 31) 2026 · New York · House · Senate

Pharmacy, Health Issues

AMERICAN COLLEGE OF CLINICAL PHARMACY for AMERICAN COLLEGE OF CLINICAL PHARMACY

1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate

Pharmacy, Medicare/Medicaid, Health Issues, Education

MR. H.R. BERT PENA for PHILLY PHARMACIES

2nd Quarter (Apr 1 - June 30) 2026 · Texas

Previous Page 14 of 72 Next

Source: federal Lobbying Disclosure Act filings. A filing's bill references are parsed from its activity descriptions, so a bill page shows the filings that named it.

Report a problem